McCulloch Kevin sold XERS
September 28, 2026 · Form 4 insider transaction
McCulloch Kevin sold 25,000 shares of Xeris Biopharma Holdings, Inc. at $10.00 per share, a transaction worth $250.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
25,000
Price
$10.00
Total value
$250.0K
InsiderMcCulloch Kevin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 28, 2026
Filing dateSeptember 29, 2026
Shares owned after1,614,208
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025.